Palatability of tablets and capsule forms of N-acetylcysteine and methionine and associated adverse events in healthy volunteers

Show simple item record

dc.contributor.author Pathiraja, V.M.
dc.contributor.author Gawarammana, I.B.
dc.contributor.author Buckley, N.A.
dc.contributor.author Mohamed, F.
dc.contributor.author Jayamanna, S.F.
dc.contributor.author Osborne, N.
dc.contributor.author Dawson, A.H.
dc.date.accessioned 2023-02-08T05:36:00Z
dc.date.available 2023-02-08T05:36:00Z
dc.date.issued 2017
dc.identifier.citation Pathiraja, V. M., Gawarammana, I. B., Buckley, N. A., Mohamed, F., Jayamanna, S. F., Osborne, N. & Dawson, A. H. Palatability of tablets and capsule forms of N-acetylcysteine and methionine and associated adverse events in healthy volunteers. Clinical Toxicology, 2017., 381-381 en_US
dc.identifier.uri http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/10865
dc.description.abstract Objective: To evaluate the palatability and adverse events associ ated with tablets and capsule forms of N-acetylcysteine (NAC) and methionine in healthy volunteers to guide the provision of cost-effective antidotes. Methods: Forty healthy students were enrolled in this single blind randomized control study. Each volunteer was randomly assigned to receive therapeutic doses of NAC (70 mg/kg) in capsules (NAC_cap), NAC tablets (NAC_tab), methionine (2500 mg) capsules (Meth_cap), methionine tablets (Meth_tab) and folic acid as a control over five weeks. Volunteers were kept isolated in 5 rooms of a tertiary care hospital and were asked to rate the taste, smell, ability to swallow, after taste and over all acceptability in a Visual Analog Scale (VAS) from 0 to 5 (100 mm) and any adverse events that occurred within 1 hour. VAS scores were analyzed by Friedman's non-parametric and Wilcoxon sign rank tests. Results: Forty students were enrolled but only 33 (9 females and 24 males) completed all 5 dosage forms. Median age was 23 (IQR 23–22) years. Palatability ratings (Table 1) for taste, smell and “ease to swallow” were similar (Friedman’s 4.7, p ¼ .19, Friedman’s 2.6, p ¼ 0.46, Friedman’s 6.5, p ¼ .09). However, there were significant differences in after taste (Friedman’s 9.8, p ¼ .02) and overall acceptability (Friedman’s 10.2, p ¼ .02). The rank order of overall acceptability was NAC_cap, NAC_tab, Meth_tab and Meth_cap with statistically significant differences (p < .01) between Meth_cap and Meth_tab, NAC_cap and Meth_cap, NAC_tab and Meth_cap. NAC_cap had a more acceptable after taste than Meth_cap (p ¼ .001). There were no reported adverse events with Meth_tab. Five reported mild nausea and two abdominal dis comfort with Meth_cap. Mild nausea was also reported with NAC_cap (n ¼ 2) and NAC_tab (n ¼ 2). Conclusion: NAC capsules were the preferred preparation, but all were palatable and tolerated sufficiently well to be used in resource poor settings. Nausea was infrequent with any preparation. en_US
dc.language.iso en en_US
dc.publisher Journal of Clinical Toxicology en_US
dc.title Palatability of tablets and capsule forms of N-acetylcysteine and methionine and associated adverse events in healthy volunteers en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account